Microdosing vs Macrodosing, Podcast Transcript
Explore the answers to a number of common questions about how psychedelics can be used in different doses.
Third Wave » Archives for Third Wave »
Explore the answers to a number of common questions about how psychedelics can be used in different doses.
Whether you’ve microdosed hundreds of times or never touched a single psychedelic substance, this webinar will be productive, informative, and insightful.
Paul Austin joins Talia Eisenberg, founder of Holistic Healer Collective, to discuss psychedelics and how they can help with immunity and immune function.
Join founder of Third Wave, Paul Austin, for an evening of discussion, insight and entertainment revolving around the topic of microdosing psychedelics.
Paul Austin talks about the responsible and intentional use of psychedelics to catalyze personal transformation in this ManTalks Interview.
The world is wondering what to do with psilocybin, one of the most promising drugs in the world. Three cities—Denver, […]
Learn about the usefulness of psilocybin therapy and why it is growing in popularity.
Popular substances include 1P-LSD, 4-AcO-DMT, 2C-B, and ALD-52.
Three closely related species – Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata – contain the psychoactive properties of the indole alkaloid ibogaine.
Although very similar in name, there are key differences to these two commonly used substances.
Used for thousands of years, cannabis has generated more attention lately as states move to medicalize and legalize it.
Although LSD is illegal nearly everywhere in the world, its close cousin, 1P-LSD, may be a legal substitute depending on your location.
Vaping CBD has become popular as an alternative option to the psychoactive effects of THC and cannabis.
Learn about the various substance specific psychedelic retreats, including ayahuasca, psilocybin mushrooms, and 5-MeO-DMT.
Research chemicals like 1P-LSD are becoming increasingly popular, especially among microdosers. Here we let you know the legal status of research chemicals.